Evidence map›Paper›PMID 20923851›Full record

ArticleMolecular pharmacology2011

CGP-37157 inhibits the sarcoplasmic reticulum Ca²+ ATPase and activates ryanodine receptor channels in striated muscle.

Jake T Neumann, Paula L Diaz-Sylvester, Sidney Fleischer, Julio A Copello

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Molecular pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Mitochondrial CaJournal of cellular physiology · 2025
    Review
  2. Review
  3. Mitochondrial CaBiomedicines · 2022
    Review
  4. Review
  5. 'Magnesium'-the master cation-as a drug-possibilities and evidences.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2021
    Review
  6. Review
  7. Article
  8. Mitochondrial Calcium Signaling in Pancreatic β-Cell.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Membrane current evoked by mitochondrial NaThe journal of physiological sciences : JPS · 2020
    Article
  11. Calcium signals that determine vascular resistance.Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  12. Pharmacological Comparisons Between Cannabidiol and KLS-13019.Journal of molecular neuroscience : MN · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mitochondrial exchanger NCLX plays a major role in the intracellular Ca2+ signaling, gliotransmission, and proliferation of astrocytes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jake T NeumannDepartment of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Paula L Diaz-Sylvester
Sidney Fleischer
Julio A Copello
Southern Illinois University School of Medicine · US

Funding

Communication neighboring ryanodine receptor channelsR01GM078665 · NIGMS · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI COPELLO, JULIO A · 2006 to 2010
$1.3M
NIGMS NIH HHS R01 GM078665NIGMS NIH HHS R01-GM078665
6 · The paper itself

Abstract

7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one [CGP-37157 (CGP)], a benzothiazepine derivative of clonazepam, is commonly used as a blocker of the mitochondrial Na+/Ca²+ exchanger. However, evidence suggests that CGP could also affect other targets, such as L-type Ca²+ channels and plasmalemma Na+/Ca²+ exchanger. Here, we tested the possibility of a direct modulation of ryanodine receptor channels (RyRs) and/or sarco/endoplasmic reticulum Ca²+-stimulated ATPase (SERCA) by CGP. In the presence of ruthenium red (inhibitor of RyRs), CGP decreased SERCA-mediated Ca²+ uptake of cardiac and skeletal sarcoplasmic reticulum (SR) microsomes (IC₅₀ values of 6.6 and 9.9 μM, respectively). The CGP effects on SERCA activity correlated with a decreased V(max) of ATPase activity of SERCA-enriched skeletal SR fractions. CGP (≥ 5 μM) also increased RyR-mediated Ca²+ leak from skeletal SR microsomes. Planar bilayer studies confirmed that both cardiac and skeletal RyRs are directly activated by CGP (EC(50) values of 9.4 and 12.0 μM, respectively). In summary, we found that CGP inhibits SERCA and activates RyR channels. Hence, the action of CGP on cellular Ca²+ homeostasis reported in the literature of cardiac, skeletal muscle, and other nonmuscle systems requires further analysis to take into account the contribution of all CGP-sensitive Ca²+ transporters.

Indexed as

AnimalsCalciumCalcium-Transporting ATPasesClonazepamMuscle, StriatedRabbitsRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumThiazepinesCalciumCalcium-Transporting ATPasesCGP 37157ClonazepamRyanodine Receptor Calcium Release ChannelThiazepines

Identifiers

PMID20923851
PMCPMC3014283
OpenAlexW2156354058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.